悦心健康: 第八届监事会第十二次会议决议公告

Group 1 - The company held its 12th meeting of the 8th Supervisory Board on May 26, 2025, with all three supervisors present, confirming compliance with legal and regulatory requirements [1][2] - The Supervisory Board approved the cancellation of stock options that were not exercised during the first exercise period of the 2023 stock option incentive plan, stating that this decision would not materially affect the company's financial status or operational results [1][2] - The decision to cancel stock options was unanimously supported by the Supervisory Board, with a voting result of 3 in favor, 0 against, and 0 abstentions [2] Group 2 - The company disclosed the decision regarding the cancellation of stock options in multiple financial publications, ensuring transparency and compliance with disclosure regulations [2] - The cancellation of stock options related to the second exercise period and the first exercise period's unfulfilled conditions was also approved, with the same assurance that it would not impact the company's financial health or shareholder interests [2]